Daily Bulletin

As A Breakthrough Drug For The Expansive Osteoporosis Market, Bogutai® (Teriparatide Injection) Has Been Officially Approved By The China National Medical Products Administration (NMPA)

HONG KONG SAR - EQS Newswire - 22 January 2024 - Uni-Bio Science Group Limited ("Uni-Bio", the "Company", together with its subsidiaries, the "Group"), a leading biopharmaceutical company, is excited to announce that the China National Medical Products Administration ("NMPA") has officially approved the marketing application for BOGUTAI® (teriparatide injection) on January 16, 2024, with the approval number "国药准字S20240004".

Business News

Tips from Organisational Change Management Experts for Leading Successful Transitions

Corporate evolution has accelerated dramatically in today's volatile business environment, requiring leaders to develop sophisticated approaches to managing workforce transitions across technologica...

Daily Bulletin - avatar Daily Bulletin

Cross-Continental Collaboration: Nutifood and Viplus Dairy to Create Australian- Standard Premium Dairy Brand

Vietnam’s Nutifood has officially entered a strategic partnership with ViPlus Dairy, a heritage-rich dairy manufacturer with over 130 years of experience in Gippsland, Australia, to establish an int...

Daily Bulletin - avatar Daily Bulletin

Beyond the Marker: How Modern Whiteboards Drive Team Collaboration

In an age where flexibility and innovation define competitive advantage, the humble whiteboard has undergone a transformation. From static office fixture to dynamic collaboration hub, modern whiteboar...

Daily Bulletin - avatar Daily Bulletin

LayBy Deals